Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing
- PMID: 6721467
- PMCID: PMC185514
- DOI: 10.1128/AAC.25.3.344
Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing
Abstract
A total of 158 volunteers each received 21 repeated oral doses of 500 mg of cefuroxime axetil (CAE) during four comparative cross-over trials. Pharmacokinetics were studied in 8 volunteers (CAE versus ampicillin), relative bioavailability and tolerance were studied in 100 volunteers (CAE versus pivmecillinam and CAE versus pivampicillin), and tolerance alone was studied in 50 volunteers (CAE versus ampicillin). Overall, urinary recoveries of the active antibiotics ranked absorption of the drugs in the order least to greatest: pivmecillinam, ampicillin, CAE, and pivampicillin. The pharmacokinetics of CAE and ampicillin did not change after repeated dosing. Peak serum levels of cefuroxime were significantly higher than those of ampicillin after doses 1 and 21 but the urinary recoveries of both antibiotics were around 35% of the dose. CAE was as well tolerated as ampicillin but there were smaller numbers of episodes of fluid bowel motions on pivmecillinam and pivampicillin than on CAE, which may have been due to the smaller amounts of active antibiotic in the doses of the pivaloyloxymethyl esters.
Similar articles
-
Cefuroxime axetil: an updated review of its use in the management of bacterial infections.Drugs. 2001;61(10):1455-500. doi: 10.2165/00003495-200161100-00008. Drugs. 2001. PMID: 11558834 Review.
-
Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.Antimicrob Agents Chemother. 1984 Jan;25(1):78-82. doi: 10.1128/AAC.25.1.78. Antimicrob Agents Chemother. 1984. PMID: 6703686 Free PMC article.
-
Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.Br J Clin Pharmacol. 1984 Oct;18(4):535-9. doi: 10.1111/j.1365-2125.1984.tb02501.x. Br J Clin Pharmacol. 1984. PMID: 6091711 Free PMC article.
-
Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.J Antimicrob Chemother. 1985 Sep;16(3):359-66. doi: 10.1093/jac/16.3.359. J Antimicrob Chemother. 1985. PMID: 4055543
-
Cefuroxime axetil.Drug Intell Clin Pharm. 1988 Sep;22(9):651-8. doi: 10.1177/106002808802200901. Drug Intell Clin Pharm. 1988. PMID: 3063476 Review.
Cited by
-
FDA-Approved Oximes and Their Significance in Medicinal Chemistry.Pharmaceuticals (Basel). 2022 Jan 4;15(1):66. doi: 10.3390/ph15010066. Pharmaceuticals (Basel). 2022. PMID: 35056123 Free PMC article. Review.
-
Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.Antimicrob Agents Chemother. 2006 Jan;50(1):68-72. doi: 10.1128/AAC.50.1.68-72.2006. Antimicrob Agents Chemother. 2006. PMID: 16377669 Free PMC article. Clinical Trial.
-
Clinical and economic considerations in the use of third-generation oral cephalosporins.Pharmacoeconomics. 1995 May;7(5):416-27. doi: 10.2165/00019053-199507050-00006. Pharmacoeconomics. 1995. PMID: 10155329 Review.
-
Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.Eur J Drug Metab Pharmacokinet. 1997 Oct-Dec;22(4):409-13. doi: 10.1007/BF03190978. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9512942
-
Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1996 Jul;52(1):125-58. doi: 10.2165/00003495-199652010-00009. Drugs. 1996. PMID: 8799689 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources